Clinical LLM benchmarks: why SNOMED CT mapping is a real-world test

TL;DR

In a world where we constantly either read “AI is going to take over everything” or “AI is useless in a medical setting”, it’s crucial to have external neutral benchmarks evaluating LLM performance for specific clinical contexts — like helping structure data from unstructured sources to SNOMED CT, the leading international clinical data standard. Congrats to Rory Davidson and team for bringing this to market.

In a world where we constantly either read “AI is going to take over everything” or “AI is useless in a medical setting”, it is crucial to have external neutral benchmarks evaluating the performance of LLMs for a specific context: helping structure data from unstructured sources to SnomedCT, the leading international clinical data standards. Congrats to Rory Davidson and the team for brining this to the market!

Key takeaways

• The public debate on AI in healthcare swings between two unhelpful extremes: total takeover or total uselessness. Neither helps practitioners decide anything.
• The corrective is external, neutral benchmarks on specific clinical tasks. Without them, evaluation stays at the level of vibes.
• Mapping unstructured clinical data to SNOMED CT is a concrete, high-value use case where LLM performance can and should be measured rigorously.
• SNOMED CT remains the leading international standard for clinical data, which makes it a meaningful benchmark target.
• Recognising teams that build this kind of benchmark infrastructure matters. It signals that rigorous evaluation is valued by the field.